J&J reports strong US OTC sales amid COVID-19

20 July 2020 - Deborah Wilkes

Premium

Johnson & Johnson’s (J&J’s) OTC sales in the US increased by almost a third in the second quarter of 2020 amid the COVID-19 pandemic. However, the US-based company’s international OTC sales dropped by 5.0% on an operational basis.

Click tags below for more information on topics:

Johnson & Johnson COVID-19

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: